(Q34330694)

1 August 2017

1 reference

title

Intensive therapies for pediatric obesity (English)

1 reference

1 August 2017

0 references

pediatric obesity

1 reference

1

1 reference

1 August 2017

1 August 2001

1 reference

Pediatric Clinics of North America

1 August 2017

1 reference

1 August 2017

48

1 reference

1 August 2017

1041-1053

1 reference

1 August 2017

4

1 reference

Role of leptin in the neuroendocrine response to fasting

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Treatment of obesity in underprivileged adolescents. Comparison of diethylpropion hydrochloride with placebo in a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Gastric bypass for morbid obesity in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Sibutramine produces dose-related weight loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

A high protein, low calorie liquid diet in the treatment of very obese adolescents: long-term effect on lean body mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Valvular heart disease associated with fenfluramine-phentermine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Feasibility of a clinic-based hypocaloric dietary intervention implemented in a school setting for obese children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Orlistat in the long-term treatment of obesity in primary care settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Obesity in childhood. A controlled trial of anorectic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Consequences of modified fasting in obese pediatric and adolescent patients: effect of a carbohydrate-free diet on serum proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Sudden Death in a Patient on a Liquid Protein Diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Congenital leptin deficiency is associated with severe early-onset obesity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Weight-reducing Effect of Diguanides in Obese Non-diabetic Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Risks and consequences of childhood and adolescent obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Is DL-fenfluramine a potentially helpful drug therapy in overweight adolescent subjects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Is Type II Diabetes Mellitus (NIDDM) a Surgical Disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Jejunoileal bypass for morbid obesity in adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Chlorphentermine as an anorexigenic agent in adolescent obesity. Report of its efficacy in a double-blind study of 30 teen-agers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Long-term morbidity and mortality in morbidly obese adolescents after jejunoileal bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Regression of hepatic steatosis in morbidly obese persons after gastric bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Gastric bypass for morbid obesity in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

One-year follow-up of weight, total body potassium, and total body nitrogen in obese adolescents treated with the protein-sparing modified fast.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Recent advances in the treatment of childhood obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Intragastric balloons in adolescents with morbid obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Gastric surgery for morbid obesity. Complications and long-term weight control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

Ten-year outcomes of behavioral family-based treatment for childhood obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970356-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70356-4

1 reference

1 August 2017

1 reference

PubMed ID

11494637